← Leaderboards
Robert Brey
Soligenix, Inc.
$21,224,085
Attributed
$21,224,085
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.1M · FY2014–17$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
Funding mix
By agency
NIH$21,224,085 · 1
By mechanism
N01$21,224,085 · 1
Top collaborators
No co-investigators on record.
Most similar at Soligenix, Inc.
Same institution · by research overlap
- Kevin James Horgan$1,337,803
- Thomas Rivenburg$7,041,180
- Oreola Donini$1,916,410
- Christopher Joseph Schaber$954,020
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesCategoriesCold ChainsCommunicable DiseasesDisease OutbreaksResponseRicin VaccineTechnologyAdvanced DevelopmentEventNational Institute Of Allergy And Infectious DiseasePathogenVaccine DevelopmentDrug FormulationsFormulationRicin
Grant awards (4)
DEVELOPMENT OF RICIN VACCINE FORMULATION$4,599,143
N01 · FY2017 · AI · contact PI
DEVELOPMENT OF RICIN VACCINE FORMULATION$8,104,724
N01 · FY2016 · AI · contact PI
DEVELOPMENT OF RICIN VACCINE FORMULATION$2,678,720
N01 · FY2015 · AI · contact PI
DEVELOPMENT OF RICIN VACCINE FORMULATION$5,841,498
N01 · FY2014 · AI · contact PI